Innovations Shines a Light on Advances in Biopharma Manufacturing and Clinical Trial Processes

Share Article

Exploring recent breakthroughs in medical manufacturing technologies.

News Image
"Exelead’s contract manufacturing organization is structured to handle small batches and formulations meant for rare disease or small populations..."

The award-winning series, Innovations with Ed Begley, Jr., will educate audiences on recent breakthroughs taking place throughout the medical industry. This episode is scheduled to air 3rd QTR, 2018. Check your local listings for more information.

Specializing in manufacturing small batch liposomal and pegylated formulas, Exelead Biopharma (Exelead) will be featured on Innovations with Ed Begley, Jr., showcasing its innovative manufacturing services for businesses from small, venture capital groups through medium and blue chip pharmaceutical companies.

Viewers will learn about Exelead’s manufacturing operation, which integrates clean room standards and cold-chain processes. In addition, the show will explore how Exelead’s laboratory scientists and GMP knowledgeable managers help companies put the finishing touches on their formulations, fulfill clinical trial processes, and manage complex logistics and delivery chain operations; taking product from molecule to market.

“Exelead is excited and honored to be a part of the Innovations series. We look forward to showcasing our core competencies and technical expertise as well as sharing our approach to partnering and managing the relationships with our clients,” said John Rigg, Exelead’s General Manager.

“Exelead’s contract manufacturing organization is structured to handle small batches and formulations meant for rare disease or small populations,” said John Galvin, producer for the Innovations series. “This information is sure to enlighten and engage audiences.”

About Exelead:
Exelead is a contract development and manufacturing organization (CDMO) dedicated to the development and commercialization of therapeutics to treat life-threatening diseases. Exelead’s core competencies focus on the manufacture of sterile drug products, specializing in liposomal and PEGylation formulation technologies. Exelead has development capabilities that can be utilized to improve drug delivery and product characterization. The Indianapolis, Indiana manufacturing facility produces proprietary parenteral pharmaceuticals for oncology and enzyme replacement treatment, as well as for the treatment of numerous infectious diseases and personalized medicine. Exelead manufactures drug products that are distributed globally and offers solutions at every phase of the drug development process (Preclinical, Phase I/II/III, and Commercial). At Exelead, our mission centers not just on what we do, but whom we serve. Exelead offers rare dedication to the customer who needs a partner – not just a CMO/CDMO.

For more information, visit: http://www.exeleadbiopharma.com.

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah McBrayer
DMG Productions
+1 866.496.4065 Ext: 802
Email >
Visit website